Foresite Capital Fund IV L.P. 13D and 13G filings for Nurix Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 3:11 pm Sale | 2021-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Foresite Capital Fund IV L.P. | 1,205,798 2.700% | -2,045,051 (-62.91%) | Filing |
| 2021-02-16 11:08 am Purchase | 2020-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Foresite Capital Fund IV L.P. | 3,250,849 8.400% | 90,065 (+2.85%) | Filing |
| 2020-08-03 3:28 pm Purchase | 2020-07-24 | 13G | Nurix Therapeutics, Inc. NRIX | Foresite Capital Fund IV L.P. | 3,160,784 8.500% | 3,160,784 (New Position) | Filing |